Moderna Covid-19 vaccine enters final stage trial this month

The announcement came shortly after the New England Journal of Medicine published results from the first stage of Moderna's vaccine trial, which showed the first 45 participants all developed antibodies to the virus. Moderna is considered to be in a leading position in the global race to find a vaccine against the coronavirus.